Diagnostic Imaging Market to 2017

PRLog (Press Release) - Aug. 2, 2012 - The US Food and Drug Administration’s (FDA) approval of Biograph mMR from Siemens has given the diagnostic imaging industry its first Positron Emission Tomography and Magnetic Resonance Imaging (PET-MRI) system. This trend of fusion of two different modalities will continue to evolve and experts in the diagnostic imaging field feel that it will be the mainstay of imaging in the coming years. Positron Emission Tomography and Computed Tomography (PET-CT) was one of the first outcomes of hybrid technology and has been successfully integrated into radiology. Radiologists have seen tremendous value in combining PET and CT and are using the hybrid modality for diagnosis and treatment planning for radiation therapy. The advantages of combining two different modalities have been manifold. PET-CT has been adopted across the globe due to its advantages in imaging anatomy as well as the physiology of the organs; this has been extremely useful in the imaging of tumors as well as in cardiac imaging.

With the Biograph mMR, Siemens was able to bring together a compact MR system with specialized PET detectors. The PET-MRI system has a 3 Tesla MR that provides the morphological and functional details of human tissue; and PET goes further to investigate the human body at the level of cellular activity and metabolism.

The diagnostic imaging industry in the US has undergone many upheavals following reimbursement cuts and a decrease in the technical component of physicians’ pay. The Deficit Reduction Act (DRA) put a cap on the technical component of imaging and computer-assisted imaging services performed in physicians’ offices. The reimbursement for the technical component has been limited to the lesser amount of what would be paid under the Hospital Outpatient Prospective Payment System or the Medicare fee schedule. This had a significant impact on   individual physicians. Reimbursement cuts, reduction in physician fee schedule and the speculation about bundled payments is having a negative impact on the diagnostic imaging market. The Patient Protection and Affordable Care Act (PPACA) and healthcare and education reconciliation act were passed as laws in 2010. The Medicare Payment Advisory Commission (MedPac) in the US issued broad-ranging criteria for imaging procedures taken up by in-office self-referred physicians and put forward various steps that could curb the self-referral practice.

For Sample Pages, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?...

Global Markets Direct’s report, “Diagnostic Imaging Market to 2017 - Fusion Technology to Increase Adoption Rates of Hybrid Imaging Systems” provides information and analysis on the global diagnostic imaging market. The report provides market landscape, competitive landscape and market trends information on Computed Tomography (CT) systems, mammography equipment Magnetic Resonance Imaging (MRI) systems, nuclear imaging systems, ultrasound systems, X-ray systems, bone densitometers, C-arms, angio suites and contrast media injectors. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and the profiles of companies operating in these geographies.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/Report.aspx?ID=Diagnos...

Visit our report store: http://www.globalmarketsdirect.com

For more details contact:
pressreleases@globalmarketsdirect.com

North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782